Logo image of PMX

PIMCO MUNI INCOME FUND III (PMX) Stock Price, Quote, News and Overview

NYSE:PMX - New York Stock Exchange, Inc. - US72201A1034 - Currency: USD

7.46  +0.07 (+0.95%)

Fundamental Rating

2

Taking everything into account, PMX scores 2 out of 10 in our fundamental rating. PMX was compared to 0 industry peers in the Unkown industry. PMX may be in some trouble as it scores bad on both profitability and health. PMX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year PMX was profitable.
In the past year PMX had a positive cash flow from operations.
PMX had positive earnings in 4 of the past 5 years.
In the past 5 years PMX always reported a positive cash flow from operatings.
PMX Yearly Net Income VS EBIT VS OCF VS FCFPMX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M

1.2 Ratios

The 3 year average ROIC (2.75%) for PMX is below the current ROIC(2.75%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.49%
ROE 5.25%
ROIC 2.75%
ROA(3y)-4.02%
ROA(5y)-0.43%
ROE(3y)-4.47%
ROE(5y)-0.12%
ROIC(3y)2.75%
ROIC(5y)2.69%
PMX Yearly ROA, ROE, ROICPMX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20

1.3 Margins

In the last couple of years the Profit Margin of PMX has grown nicely.
PMX's Operating Margin has declined in the last couple of years.
In the last couple of years the Gross Margin of PMX has remained more or less at the same level.
Industry RankSector Rank
OM 72.99%
PM (TTM) 96.18%
GM 87.73%
OM growth 3Y-1.9%
OM growth 5Y-1.53%
PM growth 3Y9.29%
PM growth 5Y76.08%
GM growth 3Y-1.9%
GM growth 5Y-0.83%
PMX Yearly Profit, Operating, Gross MarginsPMX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 -200 -300

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for PMX remains at a similar level compared to 1 year ago.
PMX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, PMX has a worse debt to assets ratio.
PMX Yearly Shares OutstandingPMX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
PMX Yearly Total Debt VS Total AssetsPMX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

PMX has an Altman-Z score of 2.21. This is not the best score and indicates that PMX is in the grey zone with still only limited risk for bankruptcy at the moment.
The Debt to FCF ratio of PMX is 1.29, which is an excellent value as it means it would take PMX, only 1.29 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.14 indicates that PMX is not too dependend on debt financing.
Even though the debt/equity ratio score it not favorable for PMX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.29
Altman-Z 2.21
ROIC/WACCN/A
WACCN/A
PMX Yearly LT Debt VS Equity VS FCFPMX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 0.00 indicates that PMX may have some problems paying its short term obligations.
PMX has a Quick Ratio of 0.00. This is a bad value and indicates that PMX is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0
Quick Ratio 0
PMX Yearly Current Assets VS Current LiabilitesPMX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 122.53% over the past year.
PMX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 66.49% yearly.
The Revenue has decreased by -8.97% in the past year.
Measured over the past years, PMX shows a decrease in Revenue. The Revenue has been decreasing by -6.84% on average per year.
EPS 1Y (TTM)122.53%
EPS 3Y2.73%
EPS 5Y66.49%
EPS Q2Q%155.12%
Revenue 1Y (TTM)-8.97%
Revenue growth 3Y-5.58%
Revenue growth 5Y-6.84%
Sales Q2Q%-6.58%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PMX Yearly Revenue VS EstimatesPMX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
PMX Yearly EPS VS EstimatesPMX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.66, which indicates a very decent valuation of PMX.
When comparing the Price/Earnings ratio of PMX to the average of the S&P500 Index (29.63), we can say PMX is valued rather cheaply.
Industry RankSector Rank
PE 11.66
Fwd PE N/A
PMX Price Earnings VS Forward Price EarningsPMX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 5.55
EV/EBITDA N/A
PMX Per share dataPMX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.18
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

PMX has a Yearly Dividend Yield of 4.87%, which is a nice return.
PMX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 4.87%

5.2 History

The dividend of PMX decreases each year by -5.34%.
PMX has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-5.34%
Div Incr Years0
Div Non Decr Years0
PMX Yearly Dividends per sharePMX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

103.30% of the earnings are spent on dividend by PMX. This is not a sustainable payout ratio.
DP103.3%
EPS Next 2YN/A
EPS Next 3YN/A
PMX Yearly Income VS Free CF VS DividendPMX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M
PMX Dividend Payout.PMX Dividend Payout, showing the Payout Ratio.PMX Dividend Payout.PayoutRetained Earnings

More info and screens

PIMCO MUNI INCOME FUND III

NYSE:PMX (2/21/2025, 8:04:00 PM)

7.46

+0.07 (+0.95%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners25.34%
Inst Owner Change19.53%
Ins Owners0.02%
Ins Owner Change0%
Market Cap249.61M
Analysts0
Price TargetN/A
Short Float %0.09%
Short Ratio0.22
Dividend
Industry RankSector Rank
Dividend Yield 4.87%
Yearly Dividend0.66
Dividend Growth(5Y)-5.34%
DP103.3%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-13 2025-02-13 (0.033)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.66
Fwd PE N/A
P/S 11.23
P/FCF 5.55
P/OCF 5.55
P/B 0.61
P/tB 0.61
EV/EBITDA N/A
EPS(TTM)0.64
EY8.58%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.35
FCFY18.03%
OCF(TTM)1.35
OCFY18.03%
SpS0.66
BVpS12.16
TBVpS12.16
PEG (NY)N/A
PEG (5Y)0.18
Profitability
Industry RankSector Rank
ROA 4.49%
ROE 5.25%
ROCE 3.49%
ROIC 2.75%
ROICexc 2.75%
ROICexgc 2.79%
OM 72.99%
PM (TTM) 96.18%
GM 87.73%
FCFM 202.47%
ROA(3y)-4.02%
ROA(5y)-0.43%
ROE(3y)-4.47%
ROE(5y)-0.12%
ROIC(3y)2.75%
ROIC(5y)2.69%
ROICexc(3y)2.75%
ROICexc(5y)2.69%
ROICexgc(3y)2.78%
ROICexgc(5y)2.72%
ROCE(3y)3.48%
ROCE(5y)3.4%
ROICexcg growth 3Y3.37%
ROICexcg growth 5Y-2.01%
ROICexc growth 3Y3.33%
ROICexc growth 5Y-2%
OM growth 3Y-1.9%
OM growth 5Y-1.53%
PM growth 3Y9.29%
PM growth 5Y76.08%
GM growth 3Y-1.9%
GM growth 5Y-0.83%
F-Score4
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.29
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 6.22
Cash Conversion N/A
Profit Quality 210.51%
Current Ratio 0
Quick Ratio 0
Altman-Z 2.21
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)122.53%
EPS 3Y2.73%
EPS 5Y66.49%
EPS Q2Q%155.12%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.97%
Revenue growth 3Y-5.58%
Revenue growth 5Y-6.84%
Sales Q2Q%-6.58%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.15%
EBIT growth 3Y-7.38%
EBIT growth 5Y-8.26%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-48.54%
FCF growth 3Y-14.57%
FCF growth 5YN/A
OCF growth 1Y-48.54%
OCF growth 3Y-14.57%
OCF growth 5YN/A